BioSpace News Archive

Omeros Corporation announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2019

Natera, Inc. reported financial results for the first quarter ended March 31, 2019 and provided an update on recent business progress.

Senseonics Holdings, Inc. reported financial results for the quarter ended March 31, 2019.

Verastem, Inc. reported financial results for the three months ended March 31, 2019.

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva®1 tablets, 100 and 150 mg, in the U.S.

Investigators from around the country presented hundreds of studies about kidney health and chronic kidney disease during the National Kidney Foundation’s 2019 Spring Clinical Meetings in Boston, May 8-12.

The California Pharmacists Association is pleased to announce that Rajan Vaidya, PharmD has joined the organization in the CPhA Center for Advocacy, the government affairs and public policy unit of the association.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has announced the pricing of its underwritten public offering of 3,750,000 shares of its common stock at a price to the public of $21.00 per share, before underwriting discounts and commissions, as detailed in the company press release.

Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), today announced that City of Hope, a world-renowned independent cancer research and treatment center, has begun enrolling patients with relapsed or treatment-resistant multiple myeloma in an innovative CS1 chimeric antigen receptor (CAR) T cell therapy (MB-104) trial.

Mettler-Toledo International Inc. announced first quarter results for 2019.